The trial will compare the therapy against a placebo in women aged 15 years and above who are diagnosed with severe PPD.

Brain cancer is the biggest cancer killer of people under 40 - but in New Zealand there is no register to keep track of the deadly disease.

BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the year ended ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Parliamentary Panel calls for setting up of a platform CTMS for Ayush clinical research: Gireesh Babu, New Delhi Wednesday, March 19, 2025, 08:00 Hrs [IST] The Parliamentary Panel ...

Positive azenosertib clinical data demonstrated clinically meaningful results in patients with Cyclin E1+ platinum-resistant ovarian cancer ...

Medscape Medical News speaks with Jiha Lee to discuss how to provide holistic, patient-centered care for older adults living ...

With the newly completed OT-101 and IL-2 Phase 1 trial, Oncotelic is poised to begin further combination trials to determine the added efficacy of OT-101, IL-2, and CKIs in solid tumors such as lung ...

PRESS RELEASE Urteste plans to start clinical trials for its pancreatic cancer test in Europe in Q3 2025 Gdansk, Poland - 27 March 2025 - Urteste S.A. (Warsaw Stock ...

Investigators should be aware that studies that meet the definition of clinical trial may be subject to additional regulatory and/or policy requirements, such as posting of consent forms on federal ...

The Egoo Phe System, developed to measure phenylalanine (Phe) levels associated with the PKU condition, is now entering its final phase ahead of initial registration in the UK and submission to a Noti ...

Observational studies and two randomized controlled trials consistently suggest that, in general, disease recurrence after ...